SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ONXX -- Ignore unavailable to you. Want to Upgrade?


To: The Fox who wrote (379)8/1/2000 8:12:08 AM
From: Jim Oravetz  Read Replies (1) | Respond to of 810
 
07:04ET Onyx Pharmaceuticals Inc. 10 7/8: Bid at $13 1/2 in pre-market following report that company's genetically engineered cancer treatment, along with chemotherapy, reduced tumors in 25 out of 30 patients with head and neck cancer. (Reuters)

source: Briefing.com
Jim